152 related articles for article (PubMed ID: 10381527)
1. Identification of a defect in the intracellular trafficking of a Kell blood group variant.
Yazdanbakhsh K; Lee S; Yu Q; Reid ME
Blood; 1999 Jul; 94(1):310-8. PubMed ID: 10381527
[TBL] [Abstract][Full Text] [Related]
2. Novel alleles at the Kell blood group locus that lead to Kell variant phenotype in the Dutch population.
Ji Y; Veldhuisen B; Ligthart P; Haer-Wigman L; Jongerius J; Boujnan M; Ait Soussan A; Luo G; Fu Y; van der Schoot CE; de Haas M
Transfusion; 2015 Feb; 55(2):413-21. PubMed ID: 25156717
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of the Kell-null phenotype: a mutation at the splice site of human KEL gene abolishes the expression of Kell blood group antigens.
Yu LC; Twu YC; Chang CY; Lin M
J Biol Chem; 2001 Mar; 276(13):10247-52. PubMed ID: 11134029
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of two novel high-prevalence antigens in the Kell blood group system, KALT and KTIM.
Lee S; Debnath AK; Wu X; Scofield T; George T; Kakaiya R; Yogore MG; Sausais L; Yacob M; Lomas-Francis C; Reid ME
Transfusion; 2006 Aug; 46(8):1323-7. PubMed ID: 16934067
[TBL] [Abstract][Full Text] [Related]
5. Changes in red cell ion transport, reduced intratumoral neovascularization, and some mild motor function abnormalities accompany targeted disruption of the Mouse Kell gene (Kel).
Zhu X; Rivera A; Golub MS; Peng J; Sha Q; Wu X; Song X; Kumarathasan P; Ho M; Redman CM; Lee S
Am J Hematol; 2009 Aug; 84(8):492-8. PubMed ID: 19544475
[TBL] [Abstract][Full Text] [Related]
6. Expansion of the Kell blood group system: two new high-prevalence antigens and two novel K0 (Kellnull ) phenotypes.
Lomas-Francis C; Vege S; Velliquette RW; Fuchisawa A; Uchikawa M; Tani Y; Moro H; Debnath AK; Westhoff CM
Transfusion; 2013 Nov; 53(11 Suppl 2):2887-91. PubMed ID: 23968329
[TBL] [Abstract][Full Text] [Related]
7. Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed Program.
Dinardo CL; Oliveira TGM; Kelly S; Ashley-Koch A; Telen M; Schmidt LC; Castilho S; Melo K; Dezan MR; Wheeler MM; Johnsen JM; Nickerson DA; Jain D; Custer B; Pereira AC; Sabino EC;
Transfusion; 2021 Feb; 61(2):603-616. PubMed ID: 33231305
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of two novel and related high-prevalence antigens in the Kell blood group system, KUCI and KANT, and their serologic and spatial association with K11 and KETI.
Velliquette RW; Hue-Roye K; Lomas-Francis C; Gillen B; Schierts J; Gentzkow K; Peyrard T; von Zabern I; Flegel WA; Rodberg K; Debnath AK; Lee S; Reid ME
Transfusion; 2013 Nov; 53(11 Suppl 2):2872-81. PubMed ID: 23560718
[TBL] [Abstract][Full Text] [Related]
9. Possible suppression of fetal erythropoiesis by the Kell blood group antibody anti-Kp(a).
Tuson M; Hue-Roye K; Koval K; Imlay S; Desai R; Garg G; Kazem E; Stockman D; Hamilton J; Reid ME
Immunohematology; 2011; 27(2):58-60. PubMed ID: 22356520
[TBL] [Abstract][Full Text] [Related]
10. Molecular defects underlying the Kell null phenotype.
Lee S; Russo DC; Reiner AP; Lee JH; Sy MY; Telen MJ; Judd WJ; Simon P; Rodrigues MJ; Chabert T; Poole J; Jovanovic-Srzentic S; Levene C; Yahalom V; Redman CM
J Biol Chem; 2001 Jul; 276(29):27281-9. PubMed ID: 11375401
[TBL] [Abstract][Full Text] [Related]
11. A combination of the effects of rare genotypes at the XK and KEL blood group loci results in absence of Kell system antigens from the red blood cells.
Daniels GL; Weinauer F; Stone C; Ho M; Green CA; Jahn-Jochem H; Offner R; Monaco AP
Blood; 1996 Nov; 88(10):4045-50. PubMed ID: 8916972
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis for the high-incidence antigens of the Kell blood group system.
Lee S; Naime DS; Reid ME; Redman CM
Transfusion; 1997; 37(11-12):1117-22. PubMed ID: 9426633
[TBL] [Abstract][Full Text] [Related]
13. The Kell blood group system.
Redman CM; Lee S
Transfus Clin Biol; 1995; 2(4):243-9. PubMed ID: 8542022
[TBL] [Abstract][Full Text] [Related]
14. Three uncommon KEL alleles in one family with unusual Kell phenotypes explain a 35-year old conundrum.
Karamatic Crew V; Poole J; Burton N; Daniels G
Vox Sang; 2014 Apr; 106(3):242-7. PubMed ID: 24795954
[TBL] [Abstract][Full Text] [Related]
15. A novel KEL*1,3 allele with weak Kell antigen expression confirming the cis-modifier effect of KEL3.
Körmöczi GF; Scharberg EA; Gassner C
Transfusion; 2009 Apr; 49(4):733-9. PubMed ID: 19347978
[TBL] [Abstract][Full Text] [Related]
16. Novel
Yearout S; Smith A; Keller J; Keller MA
Immunohematology; 2022 Jul; 38(2):51-54. PubMed ID: 35852066
[TBL] [Abstract][Full Text] [Related]
17. Genetic diversity of KELnull and KELel: a nationwide Austrian survey.
Körmöczi GF; Wagner T; Jungbauer C; Vadon M; Ahrens N; Moll W; Mühlbacher A; Ozgül-Gülce S; Kleinrath T; Kilga-Nogler S; Schönitzer D; Gassner C
Transfusion; 2007 Apr; 47(4):703-14. PubMed ID: 17381630
[TBL] [Abstract][Full Text] [Related]
18. Point mutations in KEL exon 8 determine a high-incidence (RAZ) and a low-incidence (KEL25, VLAN) antigen of the Kell blood group system.
Lee S; Reid ME; Redman CM
Vox Sang; 2001 Nov; 81(4):259-63. PubMed ID: 11904003
[TBL] [Abstract][Full Text] [Related]
19. The KEL24 and KEL14 alleles of the Kell blood group system.
Lee S; Naime D; Reid M; Redman C
Transfusion; 1997 Oct; 37(10):1035-8. PubMed ID: 9354821
[TBL] [Abstract][Full Text] [Related]
20. Another example of a KEL1 variant red cell phenotype due to a threonine to serine change at position 193 of Kell glycoprotein.
Lee-Stroka H; Slezak SL; Adams S; Martin J; Robbins FM; Caruccio L; Byrne KM; Stroncek DF
Transfusion; 2008 May; 48(5):925-9. PubMed ID: 18248571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
